Progress Update on AmbioPharm US-Based Microwave Peptide Synthesis Capabilities August 3, 2022 READ ARTICLE
AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study July 12, 2022 READ ARTICLE
Adalvo announces successful launch of Icatibant in close collaboration with strategic partner Ambio January 27, 2022 READ ARTICLE